Skip to main content
HNGE logo

HNGE · Hinge Health, Inc. · Share Buybacks

Track HNGE — free
$114.53 +0.12 (+0.10%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$9.31B
Shares
81.27M
Volume · Nov 18 1.28M Avg daily vol (3M) 1.92M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$496,500,000
as of 2026-07-29 · from Press release (reviewed)
Remaining Authorization
$496,500,000
as of 2026-07-29
Program Utilization
-0.0% $0 used of $496,500,000
Program Announced Authorized Remaining Runs Through
2026-07-29 $496,500,000 $300,000,000 —
2025-11-10 $496,500,000 $300,000,000 —
— $250,000,000 $185,000,000 —

Cash spent on buybacks by quarter

Cash deployed each quarter, with the average price paid where the company reported it. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-09-30 YTD $157,384,000
2025-12-31 $65,028,000
Key facts CIK 1673743 CUSIP 433313103 13F (30d) 350 filings 346 filers Visit website Investor relations